Cleveland Clinic
Specialty Services Symposium: Medical, Surgical and Quality
June 3, 2008 InterContinental Hotel & Bank of America Conference Center | Cleveland, Ohio

Prostate Cancer Risk Assessment

Prostate cancer is the most common cancer in men, and the second leading cause of cancer death among men in the U.S.  Every year, about 185,000 new cases of prostate cancer will be diagnosed in the United States.  About one in six men will be diagnosed with prostate cancer during his lifetime, but only one in 35 will die of it.  More than two million men alive in the United States today have been diagnosed with prostate cancer at some point.

Cleveland Clinic physicians have developed at Prostate Cancer Risk Assessment Tool, designed for men who have seen a physician regarding their prostate health.  It is based on the likelihood of diagnosing prostate cancer in approximately 2,000 men who have undergone prostate biopsy at Cleveland Clinic.  Patients will need to know a few common test results, like PSA level, in order to complete this risk assessment.  Click here to access the Prostate Cancer Risk Calculator.

For information on treatment options for more advanced disease, as well as a listing of selected clinical trials, you may download the Cleveland Clinic Treatment Guide for Prostate Cancer.

Return to Current Issue